NCT03967548View on ClinicalTrials.gov

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

PHASE1CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

May 16, 2021

Study Completion Date

June 15, 2021

Conditions

Corneal Defect

Interventions

DRUG

Germinal peptide eye drops

Germinal peptide eye drops of 0.004%

Trial Locations (1)

BJ10

Xiuli Zhao, Beijing

All Listed Sponsors

lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY